- Home
- SBUX vs BMY Comparison
SBUX vs BMY Comparison
Compare SBUX & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBUX | BMY |
|---|---|---|
| Founded | 1971 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.4B | 113.5B |
| IPO Year | 1994 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SBUX | BMY |
|---|---|---|
| Price | $106.32 | $66.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 29 | 15 |
| Target Price | ★ $104.39 | $61.73 |
| AVG Volume (30 Days) | 7.1M | ★ 11.6M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | 2.35% | ★ 4.38% |
| EPS Growth | N/A | ★ 178.46 |
| EPS | 1.62 | ★ 2.93 |
| Revenue | $37,184,400,000.00 | ★ $48,194,000,000.00 |
| Revenue This Year | $4.88 | N/A |
| Revenue Next Year | $5.15 | N/A |
| P/E Ratio | $66.62 | ★ $22.06 |
| Revenue Growth | ★ 2.79 | N/A |
| 52 Week Low | $77.99 | $42.52 |
| 52 Week High | $110.51 | $68.10 |
Technical Indicators
Market Signals| Indicator | SBUX | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 57.10 | 65.61 |
| Support Level | $101.69 | $56.46 |
| Resistance Level | $108.86 | $68.10 |
| Average True Range (ATR) | 2.87 | 1.80 |
| MACD | 0.22 | -0.12 |
| Stochastic Oscillator | 64.93 | 69.59 |
Price Performance
Historical ComparisonAbout SBUX Starbucks Corporation
Starbucks stands out as the world's biggest and most recognizable coffee brand, powered by ultracustomizable beverages in-store and a sweeping footprint of nearly 41,000 cafes in over 80 countries. About 52% are company-operated, with the balance run by licensees. The company operates roasteries and sells across its North America (74% of revenue as of the end of fiscal 2025), international (21%), and channel development (5%) segments. The brand collects revenue from company-operated stores, licensee royalties, equipment and product sales, retail ready-to-drink beverages, and packaged coffee.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.